Overview

Where the power of nature meets the logic of science for the betterment of health.
ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to our ingredient technologies unit, we also have business units focused on natural product fine chemicals, chemistry and analytical testing services, and product regulatory and safety consulting. As a result of our relationships with leading universities and research institutions, we are able to discover and acquire early stage, ingredient technologies that are protected by intellectual property.... More »

Stock Quote
NASDAQ - CDXC
Price$2.50
Change (%) Stock is Up 0.14 (5.93%)
Volume189,788
Refresh quote
Real-Time Level 2 Quote
Recent NewsMore »
DateTitle 
04/11/17ChromaDex to Showcase Novel Ingredient Science and Brand-Elevating Services at Ingredient Marketplace 2017
IRVINE, Calif., April 11, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions to dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today it is bringing some of its top industry-advancing health and wellness ingredients and services to booth #H23 at Ingredient Marketplace 2017, taking place April 19-20 in Orlando, FL.  Ingr... 
Printer Friendly Version
03/29/17ChromaDex to Present at the Cowen and Company’s 3rd Annual Future of the Consumer Conference: Convergence & Disruption on April 4, 2017
IRVINE, Calif., March 29, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients, that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today that its Chief Executive Officer and Co-Founder, Frank Jaksch, will present at Cowen and Company’s 3rd Annual Future of the Consumer Conference: Convergence & Disruption. The conferenc... 
Printer Friendly Version
03/28/17ChromaDex Appoints Steven D. Rubin, J.D., to its Board of Directors
IRVINE, Calif., March 28, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today that Steven D. Rubin, J.D. has joined the Company’s board of directors. Mr. Rubin, age 56, has served as OPKO Health, Inc.’s (NASDAQ:OPK) Executive Vice President – Administration since Ma... 
Printer Friendly Version
Upcoming EventsMore »

There are currently no events scheduled.

What's New
Download Documentation2016 Annual Report on Form 10K
Download Documentation2016 Q3 Quarterly Report on Form 10Q
Download DocumentationShareholder Letter
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Chromadex Corp posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.